These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 9853513)

  • 1. Insertion of two independent enhancers in the long terminal repeat of a self-inactivating vector results in high-titer retroviral vectors with tissue-specific expression.
    Fassati A; Bardoni A; Sironi M; Wells DJ; Bresolin N; Scarlato G; Hatanaka M; Yamaoka S; Dickson G
    Hum Gene Ther; 1998 Nov; 9(17):2459-68. PubMed ID: 9853513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retroviral vectors containing chimeric promoter/enhancer elements exhibit cell-type-specific gene expression.
    Couture LA; Mullen CA; Morgan RA
    Hum Gene Ther; 1994 Jun; 5(6):667-77. PubMed ID: 7948129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promoter choice for retroviral vectors: transcriptional strength versus trans-activation potential.
    Weber EL; Cannon PM
    Hum Gene Ther; 2007 Sep; 18(9):849-60. PubMed ID: 17767401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction of human factor IX expression vectors in retroviral vector frames optimized for muscle cells.
    Wang JM; Zheng H; Sugahara Y; Tan J; Yao SN; Olson E; Kurachi K
    Hum Gene Ther; 1996 Sep; 7(14):1743-56. PubMed ID: 8886845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hybrid retroviral vector with MCK enhancers inserted in LTR for stable and specific expression of human factor IX in skeletal muscle.
    Wang JM; Hou J; Qiu XF; Kurachi K; Xue JL
    Chin Med J (Engl); 2004 Jun; 117(6):893-8. PubMed ID: 15198894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T cell-specific expression from Mo-MLV retroviral vectors containing a CD4 mini-promoter/enhancer.
    Zhao-Emonet JC; Marodon G; Pioche-Durieu C; Cosset FL; Klatzmann D
    J Gene Med; 2000; 2(6):416-25. PubMed ID: 11199262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the relative level of gene expression from different retroviral vectors used for gene therapy.
    Byun J; Kim SH; Kim JM; Yu SS; Robbins PD; Yim J; Kim S
    Gene Ther; 1996 Sep; 3(9):780-8. PubMed ID: 8875226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retroviral vector with a CMV-IE/HIV-TAR hybrid LTR gives high basal expression levels and is up-regulated by HIV-1 Tat.
    Robinson D; Elliott JF; Chang LJ
    Gene Ther; 1995 Jun; 2(4):269-78. PubMed ID: 7552987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple modifications allow high-titer production of retroviral vectors carrying heterologous regulatory elements.
    Hlavaty J; Stracke A; Klein D; Salmons B; Günzburg WH; Renner M
    J Virol; 2004 Feb; 78(3):1384-92. PubMed ID: 14722293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of methods for somatic cell gene therapy directed against viral diseases, using retroviral vectors carrying the murine or human interferon-beta coding sequence: establishment of the antiviral state in human cells.
    Lauret E; Riviere I; Rousseau V; Vieillard V; De Maeyer-Guignard J; De Maeyer E
    Hum Gene Ther; 1993 Oct; 4(5):567-77. PubMed ID: 8280795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retroviral vectors for high-level transgene expression in T lymphocytes.
    Engels B; Cam H; Schüler T; Indraccolo S; Gladow M; Baum C; Blankenstein T; Uckert W
    Hum Gene Ther; 2003 Aug; 14(12):1155-68. PubMed ID: 12908967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue-specific gene expression from Mo-MLV retroviral vectors with hybrid LTRs containing the murine tyrosinase enhancer/promoter.
    Vile RG; Diaz RM; Miller N; Mitchell S; Tuszyanski A; Russell SJ
    Virology; 1995 Dec; 214(1):307-13. PubMed ID: 8525635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engineered long terminal repeats of retroviral vectors enhance transgene expression in hepatocytes in vitro and in vivo.
    Yamaguchi K; Itoh K; Ohnishi N; Itoh Y; Baum C; Tsuji T; Nagao T; Higashitsuji H; Okanoue T; Fujita J
    Mol Ther; 2003 Nov; 8(5):796-803. PubMed ID: 14599813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulation of alpha 1 (I) procollagen gene expression in NIH-3T3 cells by the human T cell leukemia virus type 1 (HTLV-1) Tax gene.
    Muñoz E; Suri D; Amini S; Khalili K; Jiménez SA
    J Clin Invest; 1995 Nov; 96(5):2413-20. PubMed ID: 7593629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of human glucocerebrosidase in murine macrophages: identification of efficient retroviral vectors.
    Freas-Lutz DL; Correll PH; Dougherty SF; Xu L; Pluznik DH; Karlsson S
    Exp Hematol; 1994 Aug; 22(9):857-65. PubMed ID: 8062885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new family of murine retroviral vectors with extended multiple cloning sites for gene insertion.
    Faustinella F; Kwon H; Serrano F; Belmont JW; Caskey CT; Aguilar-Cordova E
    Hum Gene Ther; 1994 Mar; 5(3):307-12. PubMed ID: 8018745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retroviral vectors produced in the cytoplasmic vaccinia virus system transduce intron-containing genes.
    Konetschny C; Holzer GW; Falkner FG
    J Virol; 2002 Feb; 76(3):1236-43. PubMed ID: 11773399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of lymphoid-specific enhancer addition or substitution in a basic retrovirus vector.
    Moore KA; Scarpa M; Kooyer S; Utter A; Caskey CT; Belmont JW
    Hum Gene Ther; 1991; 2(4):307-15. PubMed ID: 1838933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High frequency expression of integrated proviruses derived from enhancer trap retroviruses.
    Sablitzky F; Jönsson JI; Cohen BL; Phillips RA
    Cell Growth Differ; 1993 Jun; 4(6):451-9. PubMed ID: 8373730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of retroviral vector design in defined chromosomal loci by Flp-mediated cassette replacement.
    Verhoeyen E; Hauser H; Wirth D
    Hum Gene Ther; 2001 May; 12(8):933-44. PubMed ID: 11387058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.